HOME >> BIOLOGY >> NEWS
Identifying tick genes could halt disease, bioterrorism threat

WEST LAFAYETTE, Ind. - Ticks as small as a freckle can transmit a number of illnesses for which there is no vaccine and, in some cases, no cure. These creatures even could become bioterrorism weapons.

To find new ways to control the tiny animals and halt the spread of the pathogens they carry, Purdue University researchers and colleagues from the University of Connecticut Health Center, the University of Notre Dame and Massachusetts Institute of Technology are undertaking the job of unraveling the genetic makeup of one variety of the creature, called the deer or black-legged tick.

"This will be the first time researchers have explored a tick genome in depth," said Purdue's Catherine Hill, project co-principal investigator. "It's crucial to learn how ticks spread serious illnesses because of the global health threats these diseases pose.

"From a bioterrorism standpoint, it's pretty clear ticks could transmit a number of diseases that intentionally could be introduced and conveyed to people."

The scientists involved in this project have formed the International Ixodes scapularis Sequencing Committee. One of the potential outcomes of this project may be development of vaccines to block transmission of microbes that cause tick-borne illnesses, said Hill, who spearheaded efforts to gain National Institutes of Health backing for the initial stages of the tick genome venture.

Hill and her Purdue researchers are preparing materials that will be the foundation of the sequencing project, she said. She already has begun extracting RNA from ticks at different stages of their lifecycle and from different tissues in the tick. These samples will provide the scientists with the first clues as to the types of genes present in ticks and how gene expression changes when ticks are infected with disease-causing microorganisms.

"Once we begin to collect the genome data, we will analyze what the genes do and how they control tick behavior, i
'"/>

Contact: Susan A. Steeves
ssteeves@purdue.edu
765-496-7481
Purdue University
2-Sep-2004


Page: 1 2 3 4

Related biology news :

1. Identifying cancer genes Will it really lead to better treatment?
2. Identifying individuals at risk for Alzheimers disease
3. Identifying novel small RNAs
4. Breakthrough in genomic technology: Identifying the biologically relevant parts of the human genome
5. Belgian researchers explore revolutionary approach to angiogenesis
6. Tracing genes, biologists show lizard migration is traced to Florida
7. Certain genes boost fish oils protection against breast cancer
8. Fossil genes reveal how life sheds form and function
9. Missing genes may help explain why plague bacteria are so deadly
10. Do genes respond to global warming?
11. Genetic map of important tree genes outlined

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... 08, 2020 , ... Overcoming Comparability Issues in Regenerative Medicines ... Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy , ... way to complete one? Will the study comply with all FDA requirements? Understanding ...
(Date:7/1/2020)... N.J. (PRWEB) , ... July 01, 2020 , ... ... announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in ... the company’s existing Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... monoclonal antibody development services, today announced that the company has received ISO9001:2015 ... the pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 accreditation ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... (PRWEB) , ... June 30, ... ... expert tissue data insights, today announced that the launch of a new ... along with data about the tumor microenvironment (TME). , “Flagship’s TissueInsight is ...
(Date:6/28/2020)... , ... June 25, 2020 , ... ... advance photodynamic therapy for treating cancer, today announced the company has entered a ... Park”). The agreement provides Lumeda globally exclusive rights to Roswell Park intellectual ...
(Date:6/23/2020)... ... June 23, 2020 , ... DeCurtis Corporation, the premier provider ... Derek Fournier has been appointed CEO and President. Founder and former CEO, David ... , “DeCurtis Corporation has been on an incredible journey for the last twenty ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... ... innovative CNS therapies, today announced that it has filed an Investigational New Drug ... Phase 2b clinical trial of its lead drug candidate NBTX-001 in patients with ...
Breaking Biology Technology:
Cached News: